2000 Vol.18, N°5 - Suppl.21 - Table of contents
Title: Bone mass in the rheumatic diseases
Page 1
| Page | Article - [Author(s)] | Abs. | CME | Audio | Media | |
|---|---|---|---|---|---|---|
| Introduction | ||||||
| CER1481 2000,18,5,Suppl.21 Pg. 0001 | Bone mass in the rheumatoid diseases M. Mazzantini, N.E. Lane, T. Pincus › Free to View |  |  | |||
| Full Paper | ||||||
| CER1156 2000,18,5,Suppl.21 Pg. 0002-0004 | Rheumatic diseases, glucocorticoid treatment and bone mass: Recent developments M. Mazzantini, T. Pincus, N.E. Lane › Free to View | | | |||
| CER1157 2000,18,5,Suppl.21 Pg. 0005-0011 | Bone metabolism in rheumatoid arthritis J.W.G. Jacobs, R.N.J. de Nijs, W.F. Lems, J.W.J. Bijlsma › Free to View | | | |||
| CER1158 2000,18,5,Suppl.21 Pg. 0012-0015 | Bone mass in rheumatoid arthritis E.J.J.A. Kroot, R.F.J.M. Laan › Free to View | | | |||
| CER1159 2000,18,5,Suppl.21 Pg. 0016-0020 | Bone mass in ankylosing spondylitis E. Toussirot, D. Wendling › Free to View | | | |||
| CER1160 2000,18,5,Suppl.21 Pg. 0021-0026 | Bone mass and osteoarthritis J. Dequeker, F.P. Luyten › Free to View | | | |||
| CER1161 2000,18,5,Suppl.21 Pg. 0027-0034 | Bone mass in systemic lupus erythematosus L. Sinigaglia, M. Varenna, L. Binelli, F. Zucchi, D. Ghiringhelli, F. Fantini › Free to View | | | |||
| CER1162 2000,18,5,Suppl.21 Pg. 0035-0040 | The pathogenesis of glucocorticoid-induced osteoporosis R.S. Weinstein › Free to View | | | |||
| CER1163 2000,18,5,Suppl.21 Pg. 0041-0043 | Clinical and diagnostic features of glucocorticoid-induced osteoporosis L.M. Buckley › Free to View | | | |||
| CER1164 2000,18,5,Suppl.21 Pg. 0044-0048 | Calcium and vitamin D in the prevention and treatment of glucocorticoid-induced osteoporosis J.D. Ringe, H. Faber › Free to View | | | |||
| CER1165 2000,18,5,Suppl.21 Pg. 0049-0052 | Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis C. Roux, M. Dougados › Free to View | | | |||
| CER1166 2000,18,5,Suppl.21 Pg. 0053-0056 | Calcitonin in the prevention and treatment of glucocorticoid-induced osteoporosis F. Wu, I.R. Reid › Free to View | | | |||
| CER1167 2000,18,5,Suppl.21 Pg. 0057-0059 | Hormonal replacement therapy in the prevention and treatment of glucocorticoid-induced osteoporosis P. Geusens › Free to View | | | |||
| CER1168 2000,18,5,Suppl.21 Pg. 0060-0064 | Parathyroid hormone treatment for glucocorticoid-induced osteoporosis N.E. Lane, Q. Rehman › Free to View | | | |||
| CER1169 2000,18,5,Suppl.21 Pg. 0065-0058 | Fluoride in the prevention and treatment of glucocorticoid-induced osteoporosis W.F. Lems, J.W.G. Jacobs, J.W.J. Bijlsma › Free to View | | | |||
| CER1170 2000,18,5,Suppl.21 Pg. 0069-0073 | Deflazacort and bone mass V. Lo Cascio › Free to View | | | |||
| CER1171 2000,18,5,Suppl.21 Pg. 0074-0076 | New perspectives in the prevention and treatment of glucocorticoid-induced osteoporosis M.L. Brandi › Free to View | | | |||
| CER1172 2000,18,5,Suppl.21 Pg. 0079-0086 | Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis P. Boulos, J.D. Adachi › Free to View | | | |||
| CER1173 2000,18,5,Suppl.21 Pg. 0087-0092 | Methotrexate and bone mass M. Mazzantini, O. Di Munno › Free to View | | | |||
| CER1174 2000,18,5,Suppl.21 Pg. 0093-0096 | Cyclosporine and bone mass P.N. Sambrook › Free to View | | | |||
Page 1
